Polyazolyl Chelate Chemistry. 6.1 Bidentate Coordination of HB(pz)3 (pz = Pyrazol-1-yl) to Ruthenium and Osmium: Crystal Structure of [RuH(CO)(PPh3)2{κ2-HB(pz)3}]

Experimental and theoretical investigations of cyclometalated ruthenium(ii) complex containing CCC-pincer and anti-inflammatory drugs as ligands: synthesis, characterization, inhibition of cyclooxygenase and in vitro cytotoxicity activities in various cancer cell lines

The cyclometalated ruthenium(ii) complex was synthesized and studied for cytotoxicity. The interaction of Ru(ii) complex with COX-2 was studied by experimental and molecular docking.

Exploring the Ruthenium-Ligands Bond and Their Relative Properties at Different Computational Methods

We report some experimental bond distances and computational models of six ruthenium bonds obtained from DFT to higher computational methods like MP2 and CCSD. The bonds distances, geometrical RMSD, and the thermodynamic properties of the models from different computational methods are similar. It is observed that optimization of molecules of many light atoms with different functional methods results in significant geometrical variation in the values and order of the computed properties. The values of the hyperpolarizabilities, HOMO, LUMO, and isotropic and anisotropic shielding are found to depend greatly on the type of the functional used and the geometrical variation rather than on the nature of basis set used. However, all the methods rated modelled Ru-S, Ru-Cl, and Ru-O bonds as having the highest hyperpolarizabilities values. The infrared spectra data obtained from the different computational methods are significantly different from each other except for MP2 and CCSD which are found to be very similar.

Development of ruthenium-based complexes as anticancer agents: toward a rational design of alternative receptor targets

In the search for novel anticancer agents, the development of metal-based complexes that could serve as alternatives to cisplatin and its derivatives has received considerable attention in recent years. This becomes necessary because, at present, cisplatin and its derivatives are the only coordination complexes being used as anticancer agents in spite of inherent serious side effects and their limitation against metastasized platinum-resistant cancer cells. Although many metal ions have been considered as possible alternatives to cisplatin, the most promising are ruthenium (Ru) complexes and two Ru compounds, KP1019 and NAMI-A, which are currently in phase II clinical trials. The major obstacle against the rational design of these compounds is the fact that their mode of action in relation to their therapeutic activities and selectivity is not fully understood. There is an urgent need to develop novel metal-based anticancer agents, especially Ru-based compounds, with known mechanism of actions, probable targets, and pharmacodynamic activity. In this paper, we review the current efforts in developing metal-based anticancer agents based on promising Ru complexes and the development of compounds targeting receptors and then examine the future prospects.

Organometallic chemistry of ethynyl boronic acid MIDA ester, HCCB(O2CCH2)2NMe

The reactions of HCCBMIDA (BMIDA = B(O₂CCH₂)₂NMe) with a range of ruthenium complexes examples of σ-alkynyl, σ-alkenyl and vinylidene complexes bearing 4-coordinate boron substituents.

Experimental and theoretical investigation of the spectroscopic and electronic properties of pyrazolyl ligands

The electronic and spectroscopic properties of seven pyrazole derivatives are presented in order to give a clear understanding of their distinguishing features. Four out of the seven ligands are synthesised and are also characterised experimentally. A very high correlation was observed between the experimental and the theoretical IR, (1)H NMR and (13)C NMR, which help in the characterisation of the ligands. The excitation properties computed using the TDDFT shows that most of experimentally observed absorptions of the ligands are predominantly form either the HOMO or HOMO-1 to LUMO or LUMO+1. The characteristic features of the (*)N atoms (i.e. metal available coordinating centre) shows that the carboxylic unit may possibly decrease the metal affinity of the pyrazole unit while the pyridine unit will increase the affinity. The conductivity properties of the seven ligands are found to be in the order of bdmpzpy>bpzpy>bphpza>bdcpzpy>phpz>dcpz. The J-coupling of (*)NN can give an insight into the variation in their bond distance, bond stretch and bond strength in the ligands. Also the atomic properties of the (*)N atoms and their (*)NN bonds can help in the molecular characterisation, differentiation and in prediction of the non-linear optical properties of the ligands as conductive materials.

Synthesis and Characterization of Osmium(II) Trispyrazolylborate Complexes

Treatment of H2OsBr6 with excess 1,5-cyclooctadiene (cod) in boiling tert-butyl alcohol affords the polymer [OsBr2(cod)]x (1), which reacts with acetonitrile to form the mononuclear adduct OsBr2(cod)(CH3CN)2 (2). Polymer 1 reacts with potassium trispyrazolylborate (KTp) in ethanol to afford the hydride TpOs(cod)H (3) and the bromide complex TpOs(cod)Br (4). Bromide complex 4 reacts with sodium methoxide in methanol to afford TpOs(cod)OMe (5), which has been structurally characterized. Treatment of hydride 3 with methyl trifluoromethanesulfonate (MeOTf) in diethyl ether results in loss of methane and formation of the triflate complex TpOs(cod)OTf (6), which reacts with MgMe2 to give the methyl complex TpOs(cod)Me (7). The addition of bis(dimethylphosphino)methane (dmpm) to the known compound TpOs(PPh3)2Cl yields a mixture of the substitution products TpOs(eta1-dmpm)(PPh3)Cl (8) and TpOs(eta2-dmpm)Cl (9); the latter reacts with methyllithium to generate the methyl compound TpOs(dmpm)Me (10). NMR and IR data for these new compounds are reported. Crystal data for 5.MeOH at -80 degrees C are as follows: monoclinic, P2(1)/n, a = 10.728(1) A, b = 14.004(2) A, c = 13.906(2) A, beta = 102.42(6) degrees , V = 2040.3(5) A3, Z = 4, R(F) = 0.0247 for I > or = 2sigma(I), and R(wF2) = 0.0539 for all data.